Long Term Clinical Implications in Chinese Patients With Aortic Intramural Hematoma

Shenyang Northern Hospital270 enrolled

Overview

The study evaluates outcomes of intramural hematomas after long-term follow up and establish predictive factors in Chinese population.

270 intramural hematoma patients with clinical and imaging follow up were retrospectively studied in present study. The primary endpoint was consisted of aortic disease-related death, aortic dissection, penetrating atherosclerotic aortic ulcer , thickening of aorta hematoma and aortic complications requiring surgical or endovascular treatment.

Study Type

OBSERVATIONAL

Enrollment

270

Conditions

Aortic Intramural Hematoma

Interventions

drug, stent, surgical treatmentOTHER

drug, stent, surgical treatment

Eligibility

Sex: ALLMin age: 30 YearsMax age: 87 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Type A aortic hematoma * Type B aortic hematoma Exclusion Criteria: * Aortic without initial intimal flap formation.

Outcomes

Primary Outcomes

hematoma thickness and a baseline MAD

Medication and short-term imaging are recommended for Chinese IMH patients with a hematoma thickness less than 10.45 mm and a baseline MAD less than 44.75 mm. Rigorous medical observation should also be performed during the acute phase of IMH.

Time frame: 14years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.